5 Key Takeaways
-
1
Relying on single office IOP measurements may lead to unnecessarily aggressive therapy in glaucoma patients.
-
2
Diurnal fluctuations in IOP provide a more accurate assessment of disease risk than single readings.
-
3
Aggressive treatment goals must consider patient adherence and disease trajectory to avoid complications.
-
4
Targeting single-digit IOPs may increase risks without significant benefits for glaucoma patients.
-
5
Reducing IOP variability may be as crucial as lowering mean IOP in preventing disease progression.
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.







